Akero Therapeutics Inc (AKRO)
20.37
+0.23
(+1.14%)
USD |
NASDAQ |
May 21, 10:58
Akero Therapeutics Free Cash Flow: -155.88M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -155.88M |
| December 31, 2023 | -145.37M |
| September 30, 2023 | -122.25M |
| June 30, 2023 | -97.15M |
| March 31, 2023 | -94.27M |
| December 31, 2022 | -92.52M |
| September 30, 2022 | -93.70M |
| June 30, 2022 | -83.69M |
| March 31, 2022 | -84.21M |
| December 31, 2021 | -79.68M |
| September 30, 2021 | -76.38M |
| Date | Value |
|---|---|
| June 30, 2021 | -75.28M |
| March 31, 2021 | -77.83M |
| December 31, 2020 | -70.95M |
| September 30, 2020 | -59.20M |
| June 30, 2020 | -58.76M |
| March 31, 2020 | -41.50M |
| December 31, 2019 | -35.63M |
| September 30, 2019 | -26.05M |
| June 30, 2019 | -14.80M |
| March 31, 2019 | -14.73M |
| December 31, 2018 | -4.625M |
Free Cash Flow Range, Past 5 Years
-155.88M
Minimum
Mar 2024
-14.80M
Maximum
Jun 2019
-79.26M
Average
-78.76M
Median
Free Cash Flow Benchmarks
| 89bio Inc | -138.82M |
| Madrigal Pharmaceuticals Inc | -391.12M |
| Viking Therapeutics Inc | -54.87M |
| Ionis Pharmaceuticals Inc | -345.48M |
| Galectin Therapeutics Inc | -34.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -35.14M |
| Cash from Investing (Quarterly) | 57.85M |
| Cash from Financing (Quarterly) | 366.94M |
| Free Cash Flow Per Share (Quarterly) | -0.5925 |
| Free Cash Flow Yield | -13.75% |